Pictet Asset Management Holding Sa Immunovant, Inc. Transaction History
Pictet Asset Management Holding Sa
- $98.2 Billion
- Q3 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Immunovant, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 676,577 shares of IMVT stock, worth $18.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
676,577
Previous 1,188,578
43.08%
Holding current value
$18.6 Million
Previous $32.7 Million
43.08%
% of portfolio
0.02%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding IMVT
# of Institutions
214Shares Held
81.1MCall Options Held
597KPut Options Held
704K-
Deep Track Capital, LP Greenwich, CT9.73MShares$268 Million8.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.83MShares$188 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.84MShares$161 Million2.47% of portfolio
-
Baker Bros. Advisors LP New York, NY5.46MShares$150 Million1.22% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.16MShares$142 Million0.05% of portfolio
About Immunovant, Inc.
- Ticker IMVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 129,077,000
- Market Cap $3.55B
- Description
- Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...